Proximal renal tubular peptide catabolism, ammonia excretion and tubular injury in patients with proteinuria: Before and after lisinopril

Clinical Science

Volumn 94, Issue 4, 1998, Pages 425-430

  Rustom, Rana ^a   Grime, J Steve ^a   Costigan, Michael ^a   Maltby, Paul ^a   Hughes, Anthony ^a   Shenkin, Alan ^a   Critchley, Mair ^a   Bone, J Michael ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Ammonia; Aprotinin; Isoenzymes; Lisinopril; N acetyl D glucosaminidase; Proteinuria; Proximal tubular hypercatabolism

Indexed keywords

AMMONIA; APROTININ; EDETATE CHROMIUM CR 51; LISINOPRIL; N ACETYL BETA GLUCOSAMINIDASE; TECHNETIUM 99M;

ADULT; AMMONIA FORMATION; ARTICLE; CATABOLISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DEGRADATION; DRUG METABOLISM; FEMALE; HEMODYNAMICS; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY PROXIMAL TUBULE; MALE; PRIORITY JOURNAL; PROTEINURIA; URINARY EXCRETION; URINE PH;

EID: 0031955464     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0940425     Document Type: Article

References (22)

1. El Nahas AM. Mechanism of progression and consequences of nephron reduction. In: Cameron S, Davison A, Grunfeld J-P, Kerr D, Ritz E, eds. Oxford University Press: Oxford Textbook of Clinical Nephrology, 1997: 1749-88.
2. Schrier RW, Harris DCH, Chan L, Shapiro JI, Caramelo C. Tubular hypermetabolism as a factor in the progression of chronic renal failure. Am J Kidney Dis 1988; 12:243-9.
3. Agarwal KA, Nath KA. Effect of proteinuria on renal interstitium: effect of products of nitrogen metabolism. Am J Nephrol 1993; 13:376-84.
4. Nath KA, Hostetter MK, Hostetter TM. Pathophysiology of chronic tubulointerstitial disease in rats. Interaction of dietary acid load, ammonia, and complement. J Clin Invest 1985; 79: 667-75.
5. Tolins JP, Hostetter MK, Hostetter TM. Hypokalaemic nephropathy in the rat: the role of ammonia in chronic tubular injury. J Clin Invest 1987; 79: 1447-58.
6. Clark EC, Nath KA, Hostetter MK, Hostetter TM. Role of ammonia in progressive interstitial nephritis. Am J Kidney Dis 1991; 5: 15-19.
7. Rustom R, Grime JS, Maltby P, Stockdale HR, Critchley M, Bone JM. A new method to measure renal tubular degradation of small filtered proteins in man using radio-labelled aprotinin (Trasylol). Clin Sci 1992; 83: 289-94.
8. Rustom R, Grime JS, Maltby P, Stockdale HR, Critchley M, Bone JM. Observations of the early renal uptake and later metabolism of radiolabelled aprotinin in man: theoretical and practical considerations. Clin Sci 1993; 84: 231-5.
9. Rustom R, Grime JS, Maltby P, Stockdale HR, Critchley M, Bone JM. Renal tubular degradation of radiolabelled aprotinin (Trasylol) in chronic renal failure patients. Clin Sci 1993; 85: 733-6.
10. 99mTc and urinary ammonia: effects of proteinuria. Miner Electrolyte Metab 1992; 18: 108-12.
11. Costigan M, Rustom R, Shenkin A, Bone JM. Origin and significance of urinary N-acetyl β-D-glucosaminidase (NAG) in renal patients with variable function, pathology and proteinuria. Clin Chim Acta 1996; 255: 133-44.
12. De Zeeuw D, Heeg JE, De Jong PE, The antiproteinuric effect of angiotensin converting enzyme inhibitors in human renal disease. In: Andreucci E and Fine LG, eds. International Yearbook of Nephrology. London: Springer, 1992: 95-113.
13. Heeg JE, De Jong PE, De Zeeuw D. Additive antiproteinuric effect of angiotensin converting enzyme inhibition and non-steroidal anti-inflammatory drug therapy: a clue to the mechanism of action. Clin Sci 1991; 81: 367-72.
14. Björck S, Mulec H, Johnson SA, Nyberg G, Aurell M. Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy. Br Med J 1990; 300: 904-7.
15. Lewis EJ, Hunsicker LG, Bain RP, Rhode RD. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 325: 1456-62.
16. Cattran DC, Greenwood C, Ritchie S. Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no treatment. Am J Kidney Dis 1994; 23: 247-54.
17. Marauhn D. Rapid colorimetric assay of galactoside and N-acetyl-glucosaminidase in human urine. Clin Chim Acta 1976; 73: 453-61.
18. Shibasaki T, Gomi H, Ishimotot F, Miyahara TT. Urinary N-acetyl-beta-D-glucosaminidase isoenzyme activity as measured by fast protein liquid Chromatography in patients with nephrotic syndrome. Clin Chem 1990; 36: 102-3.
19. Watanabe N, Kamel S, Ohkubo A, et al. Urinary protein as measured with pyrogallol red-molybdate complex. Manually and in a Hitachi 726 Automated Analyser. Clin Chem 1986; 32: 1551.
20. Yoshida H, Kon V, Ichikawa I. Polymorphisms of the renin-angiotensin system genes in progressive renal diseases. Kidney Int 1996; 50: 732-44.
21. Chobanian MC, Julin CM. Angiotensin II stimulates ammoniagenesis in canine renal proximal tubular segments. Am J Physiol 1991; 260: F19-26.
22. Rustom R, Costigan M, Shenkin A, Bone JM. Proteinuria and renal tubular damage: urinary N-acetyl-β-D-glucosaminidase (NAG) and isoenzymes in dissimilar renal diseases. Am J Nephrol 1998 (In press).